Delivery Order SPE2DB20D1004-SPE2DB24FNCBV

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,098.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,076,308 units of Metoprolol Succinate Extended-Release 100 mg Tablets. The contract has a performance period extending through April 30, 2025 and is priced on a firm-fixed-price basis. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.36 firm fixed-price delivery order is for the supply of 1,000 units of Metoprolol Succinate Extended-Release 25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award is for the delivery of Metoprolol Succinate Extended-Release 25mg tablets in 1,000-count bottles to the Defense Logistics Agency (DLA). The $6,335.98 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 23, 2022 with a completion date of September 26, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Metoprolol Succinate Extended-Release 25 mg tablets in quantities of 1,000 per bottle. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award, valued at $2,109.25, is a Firm Fixed Price Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. This IDC, valued at up to $999,999,999.00,...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.41 firm-fixed-price delivery order is for the supply of 4,562,700 units of Metoprolol Succinate Extended-Release 50 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,052.29 firm fixed price delivery order covers the supply of 4,558,966,079 units of the prescription medication Metoprolol Succinate Extended-Release 100 mg tablets. The award has an ultimate completion date of November 3, 2022 and was made on November 2, 2022. This delivery order is part of Amerisourcebergen's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,976.48 firm fixed-price delivery order is for the supply of Metoprolol Succinate Extended-Release 100 mg tablets. The contract has an ultimate completion date of September 25, 2024 and was awarded on September 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is for the delivery of Metoprolol Succinate Extended-Release 100mg Tablets in 1,000 tablet quantities. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,302.82 and a completion date of July 20, 2023. This award is a Delivery Order, with a Firm Fixed Price pricing type. The contract does not have a set-aside...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,565,802,734 units of Metoprolol Succinate Extended-Release 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,308.84 and a period of performance through September 16, 2024. AmerisourceBergen, a for-profit organization, is not subject to any set-aside requirements for this award. The company...
This federal contract award, valued at $1,604.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of metoprolol succinate extended-release tablets, a cardiovascular medication, to support military healthcare programs. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FNCBV
    Delivery Order

This federal contract award is for the delivery of Metoprolol succinate extended-release tablets, 100 mg, in quantities of 1,000. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $2,222.45, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price and does not include any set-aside designation, indicating open competition.

Generated 2/27/25, 1:23 PM